Delayed Graft FunctionGraft SurvivalKidney TransplantationGraft Occlusion, VascularGraft RejectionCold IschemiaOrgan PreservationTissue DonorsCadaverImmunosuppressive AgentsLiving DonorsTransplantsLiver TransplantationPrimary Graft DysfunctionIslets of Langerhans TransplantationTreatment OutcomeTime FactorsWarm IschemiaBlood Vessel ProsthesisBrain DeathTissue and Organ HarvestingRetrospective StudiesKidneyPostoperative ComplicationsTissue and Organ ProcurementOrgan Preservation SolutionsCreatinineTacrolimusCyclosporinePolytetrafluoroethyleneMycophenolic AcidTransplantation, HomologousPancreas TransplantationDeathVascular PatencyFollow-Up StudiesAntilymphocyte SerumPostoperative PeriodPolyethylene TerephthalatesSaphenous VeinImmunosuppressionReoperationReperfusion InjuryDonor SelectionBlood Vessel Prosthesis ImplantationRaffinoseAnastomosis, SurgicalKidney Function TestsTransplantation, HeterotopicBiopsyLung TransplantationKidney Failure, ChronicGlomerular Filtration RateKidney Tubular Necrosis, AcuteVeinsRisk FactorsHeart TransplantationNephrectomyHistocompatibility TestingAzathioprineIschemiaRats, Inbred LewTransplantation, AutologousTransplantation, IsogeneicKidney DiseasesCoronary Artery BypassTransplantation ToleranceProspective StudiesTransplantation ImmunologyRenal DialysisAcute DiseaseGraft vs Host DiseaseArteriovenous Shunt, SurgicalAllograftsLiver FailureFemoral ArterySurvival RateIsoantibodiesJugular VeinsBiological MarkersThrombosisProsthesis DesignOliguriaKaplan-Meier EstimateCalcineurinSurvival AnalysisIncidenceAllopurinolProsthesis-Related InfectionsPopliteal ArteryRisk AssessmentTreatment FailureDiabetes Mellitus, Type 1Fetal Tissue TransplantationTechnetium Tc 99m Aggregated AlbuminRenal InsufficiencyDrug Therapy, CombinationAge FactorsSirolimusChi-Square Distribution